SynthesisAdvances in therapy2025

Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without Inhibitors.

Robert Klamroth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.